CMS just added a new behavioral health measure to the Medicare Advantage Star Ratings system. If you lead a health system with value-based care contracts tied to MA plans, the time to prepare for this requirement is now.
The measure is called DSF-E — Depression Screening and Follow-Up for Adolescents and Adults. CMS finalized it as part of the Contract Year 2027 rule. It draws on 2027 measurement year data, feeds into 2029 Star Ratings, and ultimately drives 2030 quality bonus payments. While the bonus payments are years out, the measurement period that impacts those payments starts January 2027. Building the infrastructure to deliver on this measure will take longer than most health systems expect.
Why DSF-E Matters to Health Systems
DSF-E tracks two things. Rate 1 asks whether a health plan screened its Medicare Advantage members for depression using a validated instrument and captured the result in structured LOINC code. Rate 2 asks whether patients who screened positive received documented follow-up care within 30 days of that result. CMS averages the two rates into a single measure.
The measure impacts the health plan’s Star Rating, but the execution will fall on the health system. Most value-based MA contracts include quality-gated payment mechanisms, including withholds that are only returned when quality benchmarks are met, network tiering that affects patient volume, and shared savings distributions that require clearing a quality threshold. DSF-E will likely impact all of those payment mechanisms.
A health system that cannot consistently screen its Medicare population, capture results in the right format, and document qualifying follow-up within 30 days will leave meaningful value-based care revenue on the table.
Why Current Workflows Don’t Meet DSF-E Requirements
Most health systems assume their EHR can handle this requirement because they can deploy validated assessments to patients. But moving from a positive screen to a documented follow-up within a 30-day window requires real-time alerting, gap monitoring, and intervention coordination that EHRs do not provide natively. Building those capabilities means significant IT investment, custom development, and time most health systems do not have, given the tight 2027 deadline. Luckily, health systems don’t need to build these capabilities from scratch. Technology exists that can both screen populations at scale and ensure patients are connected to the right level of care in a timely manner.
The Time to Prepare Is Now
Health systems that start investing in reliable screening infrastructure today give themselves the best chance to perform well when the measurement year begins. Waiting until 2027 to assess readiness is too late.
NeuroFlow has published a new whitepaper — A Health System’s Guide to the DSF-E Star Ratings Requirement — that breaks down exactly how the measure works, where current approaches fall short, and what it takes to meet DSF-E at scale across a Medicare population.
Download the whitepaper here to understand what’s changing, what’s at stake, and how to get ahead of it.
